Vertellus Specialties Solidifies Commitment to Life Sciences Market With Recent Global Investments

Oct 24, 2013, 08:00 ET from Vertellus Specialties Inc.

INDIANAPOLIS, Oct. 24, 2013 /PRNewswire/ -- Vertellus Specialties Inc., the world's largest producer of pyridine, picolines and pyridine derivatives, has made major recent investments to serve the needs of the global life science markets. This effort is complementary to what Vertellus has done for decades in the specialty chemical arena to serve the needs of its customers.

In China, Vertellus expanded production of specialty chemicals through a joint venture with Weifang Green Olive Chemical Co. (Green Olive). Owning the majority of the outstanding equity of the joint venture, Vertellus will leverage its industry-leading technology to produce pyridine and picolines at the facility.

In the U.S., Vertellus expanded assets for the production of pyridine derivatives for the Pharmaceutical and Agrichemical Markets.  And in Belgium, the Antwerp facility recently completed capital and other upgrades for the manufacture of Niacin (nicotinic acid) USP for pharmaceutical use.

"Vertellus is focused on serving the needs of the market through our existing broad portfolio of products," says Mark Lewis, Global Sales Director at Vertellus Specialties. "And with our technology and growth-oriented mindset we're also committed to matching the needs of emerging customers as well."

Vertellus specializes in developing and producing fine chemicals and intermediates for sophisticated chemistries as well as systems and additives that enhance the physical properties of customer end-use formulations or the manufacture of the API/AI. In addition to its diverse custom manufacturing capabilities for producing pyridine derivatives, Vertellus will showcase Vitride® Reducing Agent, Niacin USP and Citroflex® Plasticizers at the CPhI Worldwide Conference in Frankfurt, Germany, Oct. 22-24.

Vitride® Reducing Agent is used extensively in the pharmaceutical and flavor/fragrance industries as a replacement for lithium aluminum hydride. Vertellus supplies Vitride® Reducing Agent in several different pack sizes, from 1kg lab samples to 1000kg pressurized containers.

Niacin USP is now produced under cGMP and is available as an Active Pharmaceutical Ingredient.

Citroflex® Plasticizers for tablet coating will also be showcased at the conference. They offer excellent processing options, low toxicity and a long history of use in sensitive applications.

For more information, please visit booth Booth #50C01 at CPhI Worldwide, where you'll notice a new look and a glimpse of our new website being refreshed in November.  Learn more at

Vertellus:  Smart Chemistry. Our Specialty.


SOURCE Vertellus Specialties Inc.